We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
EP
201
Elkfork Partners
Oregon
$1.38M – – –
MIFH
202
Migdal Insurance & Financial Holdings
Israel
$1.3M +$379K +2,754 +43%
Canada Pension Plan Investment Board
203
Canada Pension Plan Investment Board
Ontario, Canada
$1.29M +$1.25M +9,100 New
GAM
204
Gotham Asset Management
New York
$1.21M -$3.47M -25,185 -75%
SAM
205
Securian Asset Management
Minnesota
$1.17M -$74.8K -543 -6%
Janney Montgomery Scott
206
Janney Montgomery Scott
Pennsylvania
$1.14M +$228K +1,656 +26%
OC
207
Oppenheimer & Co
New York
$1.14M -$549K -3,990 -33%
OI
208
Oakbrook Investments
Illinois
$1.14M -$117K -850 -10%
SSA
209
Schonfeld Strategic Advisors
New York
$1.12M +$1.09M +7,923 New
Robeco Institutional Asset Management
210
Robeco Institutional Asset Management
Netherlands
$1.12M +$1.09M +7,886 New
Two Sigma Advisers
211
Two Sigma Advisers
New York
$1.11M +$1.07M +7,800 New
SRAM
212
Stone Ridge Asset Management
New York
$1.09M +$234K +1,700 +28%
SAM
213
Shell Asset Management
Netherlands
$1.04M -$8.67K -63 -0.8%
SAM
214
Silvercrest Asset Management
New York
$1.01M – – –
Verition Fund Management
215
Verition Fund Management
Connecticut
$1.01M +$984K +7,146 New
PI
216
PEAK6 Investments
Illinois
$1.01M -$7.14M -51,866 -88%
TAM
217
Tyers Asset Management
Texas
$1M – – –
NFG
218
Nations Financial Group
Iowa
$993K +$951K +6,905 New
CGH
219
Crossmark Global Holdings
Texas
$990K -$23.4K -170 -2%
VFA
220
Voya Financial Advisors
Connecticut
$984K +$83.8K +609 +10%
Mercer Global Advisors
221
Mercer Global Advisors
Colorado
$972K -$137K -993 -13%
MWNA
222
Marshall Wace North America
New York
$889K +$863K +6,271 New
WTC
223
WhitTier Trust Company
Nevada
$866K +$132K +959 +19%
PA
224
Profund Advisors
Maryland
$864K -$255K -1,852 -23%
BB
225
Bell Bank
North Dakota
$857K -$10.1K -73 -1%
7 8
9
10 11

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.